Literature DB >> 24725182

High incidence of morbidity following resection of metastatic pheochromocytoma in the spine.

Paul E Kaloostian1, Patricia L Zadnik, Jennifer E Kim, Mari L Groves, Jean-Paul Wolinsky, Ziya L Gokaslan, Timothy F Witham, Ali Bydon, Daniel M Sciubba.   

Abstract

Pheochromocytomas of the spine are uncommon and require careful preoperative planning. The authors retrospectively reviewed the charts of 5 patients with metastatic spinal pheochromocytoma who had undergone surgical treatment over the past 10 years at their medical center. They reviewed patient age, history of pheochromocytoma resection, extent and location of metastases, history of alpha blockage, surgical level, surgical procedure, postoperative complications, tumor recurrence, and survival. Metastases involved the cervical (1 patient), thoracic (3 patients), and lumbar (2 patients) levels. Preoperative treatment included primary pheochromocytoma resection, chemotherapy, alpha blockade, embolization, and radiation. Three patients had tumor recurrence, and 2 underwent 2-stage reoperations for tumor extension. Hemodynamic complications were common: 2 patients developed pulseless electrical activity arrest within 4 months after surgery, 1 patient had profound postoperative tachycardia with fever and an elevated creatine kinase level, and 1 patient experienced transient postoperative hypotension and paraplegia. One patient died of complications related to disseminated cerebral and spinal disease. With careful preoperative and surgical management, patients with symptomatic metastatic spinal pheochromocytoma can benefit from aggressive surgical treatment. Postoperative cardiovascular complications are common even months after surgery, and patients should be closely monitored long term.

Entities:  

Keywords:  CK = creatine kinase; MIBG = metaiodobenzylguanidine; PEA = pulseless electrical activity; en bloc; oncology; spinal pheochromocytoma; spinal tumor

Mesh:

Year:  2014        PMID: 24725182     DOI: 10.3171/2014.3.SPINE13535

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  7 in total

1.  Role of miR-101 in pheochromocytoma patients with SDHD mutation.

Authors:  Ligeng Zong; Lizhen Meng; Ruhui Shi
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Clinical features and prognosis analysis of metastatic spinal pheochromocytoma: A single center retrospective study.

Authors:  Shuzhong Liu; Xi Zhou; Zhen Huo; Siyuan Yao; Yipeng Wang; Yong Liu
Journal:  J Bone Oncol       Date:  2020-08-02       Impact factor: 4.072

Review 3.  En Bloc Resection of Solitary Functional Secreting Spinal Metastasis.

Authors:  C Rory Goodwin; Michelle J Clarke; Ziya L Gokaslan; Charles Fisher; Ilya Laufer; Michael H Weber; Daniel M Sciubba
Journal:  Global Spine J       Date:  2015-07-16

4.  Successful treatment of metastatic pheochromocytoma in the spine with cement augmentation.

Authors:  Siyi Cai; Xiangyi Kong; Chengrui Yan; Yong Liu; Xi Zhou; Guixing Qiu
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

Review 5.  Malignant pheochromocytoma with multiple vertebral metastases causing acute incomplete paralysis during pregnancy: Literature review with one case report.

Authors:  Shuzhong Liu; An Song; Xi Zhou; Xiangyi Kong; William A Li; Yipeng Wang; Yong Liu
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

6.  Successful treatment of malignant pheochromocytoma with sacrum metastases: A case report.

Authors:  Shuzhong Liu; Xi Zhou; An Song; William A Li; Radhika Rastogi; Yipeng Wang; Yong Liu
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

7.  Surgical Treatment of Malignant Pheochromocytomas in Spine.

Authors:  Shu-Zhong Liu; Xi Zhou; An Song; Zhen Huo; Yi-Peng Wang; Yong Liu
Journal:  Chin Med J (Engl)       Date:  2018-11-05       Impact factor: 2.628

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.